Marc Hermanus Gerardus Petrus Raaijmakers
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marc Hermanus Gerardus Petrus Raaijmakers has a total of 269 co-authors. Here are the top co-authors by number of shared publications:
- Mathijs Arnoud Sanders
Department of Hematology, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands
60 shared publications - Remco M. Hoogenboezem
Department of Hematology, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands
60 shared publications - Tom Cupedo
Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
60 shared publications - Paola Pisterzi
Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
46 shared publications - Bob Löwenberg
Department of Hematology, Erasmus MC, Rotterdam, The Netherlands, Rotterdam, Netherlands
45 shared publications - Claire van Dijk
Department of Hematology, Erasmus Medical Center Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands
45 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Figure S10 from Spatial Profiling Identifies a Distinct and Topographically Defined Tumor Microenvironment that Emerges during Multiple Myeloma Evolution
Validation of the myeloma tumor microenvironment using an independent publicly available spatial transcriptomics cohort.
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S10 from Spatial Profiling Identifies a Distinct and Topographically Defined Tumor Microenvironment that Emerges during Multiple Myeloma Evolution
Validation of the myeloma tumor microenvironment using an independent publicly available spatial transcriptomics cohort.
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Figure S1 from Spatial Profiling Identifies a Distinct and Topographically Defined Tumor Microenvironment that Emerges during Multiple Myeloma Evolution
Spatial transcriptomics cellular annotation and quality control.
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Spatial Profiling Identifies a Distinct and Topographically Defined Tumor Microenvironment that Emerges during Multiple Myeloma Evolution
Spatial transcriptomics cellular annotation and quality control.
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Figure S11 from Spatial Profiling Identifies a Distinct and Topographically Defined Tumor Microenvironment that Emerges during Multiple Myeloma Evolution
Neighborhood and interaction dynamics across disease stages and plasma cell architecture.
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S11 from Spatial Profiling Identifies a Distinct and Topographically Defined Tumor Microenvironment that Emerges during Multiple Myeloma Evolution
Neighborhood and interaction dynamics across disease stages and plasma cell architecture.
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Data from Spatial Profiling Identifies a Distinct and Topographically Defined Tumor Microenvironment that Emerges during Multiple Myeloma Evolution
The pathobiology of multiple myeloma is influenced by cells of the bone marrow (BM), but whether tumor support is organized in a spatially defined tumor microenvironment (TME) remains unclear. Using spatial transcriptomics and imaging mass cytometry, we show that myeloma cells initially exist as scattered cells throughout the marrow, yet with disease evolution condense into a spatially defined TME. Dense tumor nodules contain a cellular ecosystem distinct from the surrounding marrow, enriched for macrophages, conventional dendritic cells, and CD8+ T cells, as well as endothelial cells and THY1+ mesenchymal stromal cells. Conversely, neutrophil lineage cells are absent from this TME but interact with scattered myeloma cells outside of dense nodules. The presence of the dense tumor architecture at diagnosis confers a worse prognosis, emphasizing the relevance of spatial organization of the BM. Together, these findings define a discrete spatial and cellular myeloma TME that provides spatially guided insights into patient stratification and disease pathobiology. Significance:This study provides identification of a topographically defined TME for multiple myeloma, with a specific cellular ecosystem. This TME develops during disease evolution and is linked to worse outcomes in newly diagnosed patients. Our work provides insight into the interplay of tumor evolution and spatial organization in multiple myeloma.
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Spatial Profiling Identifies a Distinct and Topographically Defined Tumor Microenvironment that Emerges during Multiple Myeloma Evolution
The pathobiology of multiple myeloma is influenced by cells of the bone marrow (BM), but whether tumor support is organized in a spatially defined tumor microenvironment (TME) remains unclear. Using spatial transcriptomics and imaging mass cytometry, we show that myeloma cells initially exist as scattered cells throughout the marrow, yet with disease evolution condense into a spatially defined TME. Dense tumor nodules contain a cellular ecosystem distinct from the surrounding marrow, enriched for macrophages, conventional dendritic cells, and CD8+ T cells, as well as endothelial cells and THY1+ mesenchymal stromal cells. Conversely, neutrophil lineage cells are absent from this TME but interact with scattered myeloma cells outside of dense nodules. The presence of the dense tumor architecture at diagnosis confers a worse prognosis, emphasizing the relevance of spatial organization of the BM. Together, these findings define a discrete spatial and cellular myeloma TME that provides spatially guided insights into patient stratification and disease pathobiology. Significance:This study provides identification of a topographically defined TME for multiple myeloma, with a specific cellular ecosystem. This TME develops during disease evolution and is linked to worse outcomes in newly diagnosed patients. Our work provides insight into the interplay of tumor evolution and spatial organization in multiple myeloma.
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Figure S2 from Spatial Profiling Identifies a Distinct and Topographically Defined Tumor Microenvironment that Emerges during Multiple Myeloma Evolution
Spatial transcriptomics cellular annotation overview.
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Spatial Profiling Identifies a Distinct and Topographically Defined Tumor Microenvironment that Emerges during Multiple Myeloma Evolution
Spatial transcriptomics cellular annotation overview.
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from Spatial Profiling Identifies a Distinct and Topographically Defined Tumor Microenvironment that Emerges during Multiple Myeloma Evolution
Cellular localization and plasma cell-density analysis.
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Spatial Profiling Identifies a Distinct and Topographically Defined Tumor Microenvironment that Emerges during Multiple Myeloma Evolution
Cellular localization and plasma cell-density analysis.
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Figure S12 from Spatial Profiling Identifies a Distinct and Topographically Defined Tumor Microenvironment that Emerges during Multiple Myeloma Evolution
Association of bone marrow nodule growth patterns with clinical outcome.
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S12 from Spatial Profiling Identifies a Distinct and Topographically Defined Tumor Microenvironment that Emerges during Multiple Myeloma Evolution
Association of bone marrow nodule growth patterns with clinical outcome.
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Figure S4 from Spatial Profiling Identifies a Distinct and Topographically Defined Tumor Microenvironment that Emerges during Multiple Myeloma Evolution
Cellular composition differences across the myeloma disease spectrum.
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Spatial Profiling Identifies a Distinct and Topographically Defined Tumor Microenvironment that Emerges during Multiple Myeloma Evolution
Cellular composition differences across the myeloma disease spectrum.
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Figure S7 from Spatial Profiling Identifies a Distinct and Topographically Defined Tumor Microenvironment that Emerges during Multiple Myeloma Evolution
Structural annotation and immunofluorescence imaging.
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from Spatial Profiling Identifies a Distinct and Topographically Defined Tumor Microenvironment that Emerges during Multiple Myeloma Evolution
Structural annotation and immunofluorescence imaging.
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from Spatial Profiling Identifies a Distinct and Topographically Defined Tumor Microenvironment that Emerges during Multiple Myeloma Evolution
Segmentation and annotation of imaging mass cytometry images.
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Spatial Profiling Identifies a Distinct and Topographically Defined Tumor Microenvironment that Emerges during Multiple Myeloma Evolution
Segmentation and annotation of imaging mass cytometry images.